Study Links mRNA 'Vaccines' to Deadly Cancer Surge

A new study has linked Covid mRNA “vaccines” to long-term health risks, including cancer development.

A preprint study led by Natalia von Ranke and John A. Catanzaro, from Neo7Bioscience and the McCullough Foundation, has raised alarm bells over potential long-term health impacts of mRNA injections.

The study, published on Preprints, investigates whether new-onset adverse events and cancers following mRNA vaccination are linked to dangerous disruptions in gene expression.

The authors argue that synthetic mRNA “vaccines” may be contributing to the rise in deadly cancers by inducing lasting changes in mitochondrial function, immune response, and oncogenic pathways.

This observational study analyzed RNA sequencing data from peripheral blood samples.

The dataset included three individuals with nonmalignant post-vaccination adverse events, seven with new-onset cancers following vaccination, and 803 healthy controls.

Using differential expression analysis (DESeq2) and gene set enrichment analysis (GSEA) with MSigDB pathways, the study aimed to uncover any links between vaccination and transcriptomic dysregulation.

The findings were deeply concerning and reveal disturbing signals of stress and immune dysfunction.

The researchers analyzed two groups of “vaccinated” individuals: those with adverse events and those with cancer

Both groups of individuals affected by the injections exhibited significant changes in their gene expression profiles compared to the healthy control group.

The individuals in the first group (adverse events) showed distinct disruptions in mitochondrial function, proteasomal degradation, and systemic inflammation.

The researchers note that all of these issues are key markers of cellular stress.

Meanwhile, the second group (cancer cases) presented additional alarming features, including genomic instability, epigenetic changes, and abnormal immune signaling pathways, notably heightened interferon and TLR signaling, which are commonly associated with cancer development.

Both groups exhibited upregulation of genes involved in nonsense-mediated decay, ribosomal stress, and MYC signaling, a known cancer-promoting pathway.

Another concerning observation was the downregulation of ACE2 expression in cancer patients, as well as changes in DNA methylation patterns, which can lead to the silencing of tumor-suppressor genes.

The findings of this exploratory study suggest the disturbing possibility that mRNA “vaccines” may be contributing to not only acute adverse events but also long-term health issues like cancer.

The authors highlight that these post-vaccination symptoms, including cancer, align with signs of cellular stress, immune dysregulation, and abnormal cell proliferation, all of which could point to serious risks associated with synthetic mRNA technology.

While this study is still in its early stages and has yet to undergo peer review, the authors emphasize the urgent need for broader surveillance and ongoing research into the long-term effects of mRNA vaccines on gene expression.

Given the rise in cancer cases globally, the scientific community must explore potential links between these mRNA shots and the increase in cancers, especially considering the data presented here.

The authors are calling for more attention to the potential dangers of mRNA vaccine technology, urging caution when it comes to the future use of these “vaccines.”

With mounting evidence from various sources suggesting potential long-term health risks, including cancer, it is essential that these concerns are fully investigated before further “vaccine” rollouts or mandates are considered.

As the study underscores, the stakes are high.

The consequences of not fully understanding the long-term effects of these vaccines on gene expression could be catastrophic for public health.

If this research proves accurate, the ramifications for the global population could be severe.